Premium Essay

Cancer Drugs

In: Business and Management

Submitted By leecrabtree
Words 1942
Pages 8
1

The Costs and challenges of the Production of Cancer Drugs
Hearing the words “you have cancer,” are only the beginning of a long and horrible experience made only more difficult for the afflicted by the complexity of getting a successful treatment to those that need it. The processes of getting effective treatments to patients are influenced by economic issues, the special medical needs of those served, and by the Federal Drug Administration making sure that the risks and costs of the treatment don’t outweigh the benefits.
The cost of cancer involves the cost of treatment, the cost of research, and the cost of FDA processes to get the treatments and drugs to the market. Even when the economy is good these are difficult things to meet. The costs of cancer treatment can be so devastating to both insured, and uninsured that cancer stricken patients sometimes decide not to take the treatments. Decisions must be made whether to pay the mortgage, or pay for treatments that may or may not cure the cancer.
A cure for cancer has not yet been found .This year, about 580,350 US residents are expected to die of cancer, that’s nearly 1,600 people a day. Cancer is the second most common cause of death in the United States, exceeded only by heart disease. Cancer accounts for nearly one out of every four deaths in the United States (American Cancer Society, Last Revised: 02/01/2013,http://www.cancer.org/cancer/cancerbasics/economic-impact-of-cancer) According to the American Cancer Society, The financial costs of cancer are high for both the person with

2 cancer, and for society as a whole. The National Institutes of Health estimated the 2008 overall annual costs of cancer total were 201.5 billion dollars. The direct medical costs which were the total of all health expenditures totaled to be 77.4 billion dollars. The Indirect mortality costs…...

Similar Documents

Free Essay

Cancer Drug Shortage

...injected drugs, which are the workhorses of hospitals but are difficult to make and produce little profit for drugmakers. The shortages are caused primarily by problems with sterility and other serious issues that have led to shutdowns of production lines and occasionally entire factories. In addition, consolidation among generic drug manufacturers, as well as manufacturers deciding to end production of marginally profitable drugs, has led to decreased capacity. That means when one manufacturer suddenly stops production, the small number of others making a drug can't quickly pick up slack. A MAJOR PRODUCTION FACILITY OF THE DRUG WAS SHUT DOWN IN NOVEMBER  there are no routine mechanisms in place requiring manufacturers to notify anyone formally that a drug may be entering into a shortage phase, why the drug is entering the shortage phase, and how long it will be in short supply. 2. The FDA said it will temporarily allow importation of a replacement drug for Doxil, a drug for ovarian and other cancers that hasn't been available for new patients for months.  The agency also approved another supplier for a preservative-free version of methotrexate, a crucial drug for children with a type of leukemia calledacute lymphoblastic leukemia and for high-dose treatment of bone cancer. The version with preservatives can be toxic or cause paralysis in children and other patients getting the drug high doses. THE DRUG SHORTAGE PREVENTION ACT Now the FDA is importing the drugs......

Words: 375 - Pages: 2

Premium Essay

Cancer Drug for Alzheimers

...Cancer drug may have Alzheimer’s benefits By Laura Sanders, Science News Publisher: Science News Date Published: March 10, 2012 Alzheimer’s a disease that progressively attacks the brain’s nerve cells which results in many changes in behavior, memory and thinking skills. Scientists have been studying this disease for decades and have yet to come up with any drug that can cure or help cure this disease, until recently that is. Cramer of Western Reserve University School of Medicine in Cleveland took a drug called bexarotene and injected it into mice that have Alzheimer’s. Bexarotene has been around for over ten years and is used as a second treatment of T-cell lymphoma. Cramer and her colleagues studied mice whose brains were full of both types of A-beta plaques. A-beta called amylod-beta exists in small fragments that scramble the nerve cell communication and there are large sticky clumps called plaques. The team gave a dose of the bexarotene to the mice and watched over the next fourteen days to see what would happen. Within the first twenty-four hours the levels of A-beat plaque fell by 25 percent and within the 14 days after given the bexarotene the mice A-beta plaques fell by 75 percent. Bexarotene targets the protein that carries ApoE and tries to regulate it from causing Alzheimer’s. ApoE is a big cause of Alzheimer’s as it tries to carry A-beta from the brain. Cramer ran another test of the memory of the mice. Cramer noted that generally when you put...

Words: 664 - Pages: 3

Premium Essay

Finding Different Drugs to Cure Cancer

...ASSIGNMENT 3.1: FINDING DIFFERENT DRUGS TO CURE CANCER by Wanda G. Sellers August 21, 2013 English 115 Instructor: Professor Audrey L. Vaughan Cancer is a very devastating disease. It attacks every organ in the human body. Many people in the United States and in foreign countries have cancer. Cancer affects many people’s lives and many more people are being diagnosed with cancer each day. Everyday scientists and researchers are trying to come up with new medicines to cure cancer. In this paper, I will discuss the process of developing new drugs to treat cancer, and the costs of developing these drugs. According to the oncologists at the website Cancer.net, more doctors and scientists are always looking for better ways to treat people with cancer. To do this, they are constantly developing and studying new drugs as well as looking for new ways to use the existing drugs. When scientists are developing new drugs for cancer patients, there are many researchers involved. They must find the right chemicals before testing them to see how effective they are in helping people. Sometimes this process takes from 5 to 12 years. Sometimes it takes longer than that. After the new drugs are developed, more time has to be allowed for the Food and Drug Administration (FDA) to approve the drugs before cancer patients can take them according to Cancer.net. They do this by......

Words: 718 - Pages: 3

Free Essay

Expensive Cancer Drugs: a Comparison Between the United States and the United Kingdom

...Research Assignment Article: Expensive Cancer Drugs: A Comparison between the United States and the United Kingdom. The article that I will do an overview on is entitled: Expensive Cancer Drugs: A Comparison between the United States and the United Kingdom. The article compared the United Kingdom’s and the United States experience with cancer drugs and how expensive they can be due to medical technologies. This article also discusses the differences between the two countries access to new cancer drugs and their cancer outcomes. Most think that the wealthy can buy their way to new medical technologies and treatments but is this true? This article breaks down how it is possible for the wealthy and the low income population can to receive cancer drugs in both the United Kingdom and in the United States. The United Kingdom’s National Health Service (NHS) is funded by a general taxation system with a budget that is set every 3 years by government. This service is offered to the citizens of the United Kingdom can receive healthcare regardless of financial status. NHS is the main care provider for the majority of the population. When it comes to the least restrictive pharmaceutical pricing and reimbursement the United Kingdom has it. The surprising thing abut the NHS I found was almost all cancer drugs become free at the point of service using taxpayers money allocated to them by the government for the resident’s needs. Not all drugs are offered free. The Health and Clinical......

Words: 802 - Pages: 4

Premium Essay

Anti-Cancer Drug Cost Regulations- Cocontainment for the Pharmaceutical Companies

...Anti-Cancer Drug Cost Regulations- Cost-Containment for the Pharmaceutical Companies Brenda Roberson University of Maryland University College Abstract Drug development is a long, inefficient, and expensive process and takes 10 to 15 years for development at a cost of about $1.3 billion (Nelson, 2014). When speaking of research and development (R&D) for new drugs; a large number of drugs that go through research do not make it to the FDA or the marketplace. Critics of pharmaceutical companies point out that only a small portion of the pharmaceutical companies’ expenditures account for research and development (R&D). The majority of the money’s spent in marketing and administration. There is also controversy over the $1.3 billion figure as an actual cost. Reported by Nelson (2014) Dr. Kantarjian of M.D. Anderson disputes the $1.3 billion figure for development; he believes this figure to be inflated to cover ancillary expenses, salaries, bonuses, stock market returns, and other indirect costs not related to R&D. The cost of cancer drug therapy is becoming impossible to justify or rationalize for both patient and society. New cancer drugs being approved by the Food and Drug Administration (FDA) are typically costing upwards of $100,000 per year and many times used in combination with other agents (Bunnell, 2012, p. 932) increasing the cost even more. These high priced anti-cancer drugs achieve only marginal benefit for the patient. Benefits achievements of...

Words: 2794 - Pages: 12

Free Essay

Cancer Treatments

...think of a few people you know personally that have battled cancer or are battling it right now. Do you ever think about the drugs that it takes to keep them healthy or how their produced? It's a long process, but it is most certainly worth the wait. These drugs save lives. Approximately 7.6 million people die from cancer each year and most of these deaths can be prevented. Drugs like Herceptin(breast cancer) and Methotrexate(lung cancer) are tested to prevent deaths that can be avoided all together. There are several different types of cancer, which means there is a demand for several different drugs to fight each type of cancer. These drugs are needed to keep the patients healthy. The treatments are needed to take cancerous cells out of the body and to also make sure the cancer won't come back. The fact that these deaths can be avoided is all the more reason to keep producing new drugs. The FDA, also known as the U.S. Food and Drug Administration are responsible for making sure all drugs are effective and safe before they are able to go on the market. The public's health and speeding up the testing process to make medicine more affordable, effective and safer is their job. The FDA's main goal is to maintain the public's health by regulating the food and drugs that are given out to the public. Drugs that are available to the public are always tested for quality purposes. The FDA has many tasks, from testing the drugs multiple times, to making them affordable and......

Words: 1268 - Pages: 6

Premium Essay

The Business of Developing New Drugs

...The Business of Developing New Drugs for Cancer Larry Cephas Strayer University Developing new drugs for cancer and or any other medical purpose is a tedious, complex, expensive process. The process in developing new drugs involves numerous stages of trial and error. According to Mahajan and Gupta (2010) on average it can cost anywhere from US$ 802million to US$ 1billion dollars to successfully develop and market new drugs and, that process can take up to 12years with on average of only 8% of them ever hitting the market. From the beginning of civilization, people have been concerned regarding the quality and safety of medicines, which I do not fault anyone because, some medicines just do not work out to be very effected and good for the human body. My purpose of this white paper is to inform you and outline the various steps and procedures that goes into developing these new drugs for cancer, the economic issues people with face today, the special needs being served and the benefits of these new drugs and methods of how they are being developed, and finally based on my research the end result once these newly developed drugs reach the consumers. The Development of New Drugs The steps involved in developing new drugs for cancer patients are very complex (Figure 1). According to a fact sheet released by the California Biomedical Research Association there are several steps taken when developing a new drug. The first step involved is the preclinical research, in which......

Words: 1502 - Pages: 7

Premium Essay

Developing New Drugs

...Developing New DrugsThe Business of Developing New Drugs for Cancer Larry Cephas Strayer University Developing new drugs for cancer and or any other medical purpose is a tedious, complex, expensive process. The process in developing new drugs involves numerous stages of trial and error. According to Mahajan and Gupta (2010) on average it can cost anywhere from US$ 802million to US$ 1billion dollars to successfully develop and market new drugs and, that process can take up to 12years with on average of only 8% of them ever hitting the market. From the beginning of civilization, people have been concerned regarding the quality and safety of medicines, which I do not fault anyone because, some medicines just do not work out to be very effected and good for the human body. My purpose of this white paper is to inform you and outline the various steps and procedures that goes into developing these new drugs for cancer, the economic issues people with face today, the special needs being served and the benefits of these new drugs and methods of how they are being developed, and finally based on my research the end result once these newly developed drugs reach the consumers. The Development of New Drugs The steps involved in developing new drugs for cancer patients are very complex (Figure 1). According to a fact sheet released by the California Biomedical Research Association there are several steps taken when developing a new drug. The first step involved is the......

Words: 1507 - Pages: 7

Free Essay

Informative Cancer Brochure

...Informative Brochure ENG115 Cancer is a disease, caused by abnormalities in the genetics of transformed cells. It appears in a variety of areas throughout the human body including the lungs, heart, brain, and even the skin. In the U.S. most people with cancer have it in areas that aren’t even widely know as a main area that contracts the disease. Although there is no widely known cure for cancer, there are many ways to treat it and prolong the life of those affected by it. There are many companies involved in the research and development of new drugs for the treatment of cancer patients, many of which hope to one day accomplish the ultimate goal of curing this atrocious disease. The process of developing the drugs that treat cancer is a long and meticulous one. In order for a new treatment to become available to patients, it must first go through a series of experiments. When a company wants to market a new drug to the public, it submits an NDA (New Drug Application) to the FDA for review. The company must prove through this application that the drug has been tested and is safe and effective (1.). But, even though it may pass as a safe drug to distribute, in the best interests of the developing company, it must also be economically cost effective. When developing a new treatment for cancer patients, some companies come across treatments that come from the hormones of animals. In cases like this, harvesting the animals for these hormones becomes an economic......

Words: 816 - Pages: 4

Free Essay

Cancer

...with cancer? As crazy as it sounds, most people assumes that the cancer patient has no way out to survive and may have couple months or one to two years of survival time. Yes! it’s true that patients die out of cancer because it’s a disease in which abnormal cells spreads out without any control and are able to invade other tissues. What if cancers have medication in which it shows patients can survive? As we all know, there are more than hundred types of cancer and for each type there are different drugs but do all of them gives the chance to survive? In today's date, we have so many prostate cancer drugs that gives extra months to survive and may even cure cancer completely. The drugs that are approved by the Food and Drug Administration are: Abiraterone Acetate, Cabazitaxel, Degarelix, Docetaxel, Jevtana, Leuprolide Acetate, Lupron, Lupron Depot, Lupron Depot-3 and 4 months, Lupron Depot-Ped, Prednisone, Provenge, Sipuleuce, Taxotere, Viadur and Zytiga. Denosumab a new prostate cancer drug which has been approved by FDA delayed the spread of the cancer cells to the bone. The drug is used to treat osteoporosis and fractures with bone metastases from solid tumors. Researchers considered denosumab as a trial to see if it can delay the risk of the cancer cells reaching to the bones. To conduct the results, there was a research done that included more than 1,400 participants from thirty different countries. As a result, male cancer patients that tried the drug......

Words: 872 - Pages: 4

Free Essay

The Public Needs to Know

... Joshua Hall Eng115 Professor Kimberly Sinnott 06/11/13 Developing new drugs for cancer patients has many issues that slows production of effective drugs. Cancer treatments and research for new and better medicine is one of the largest and most expensive developments. Trail and error in producing effective medication is extremely grueling. This has been going on for years,It has always been a problem with the managing of good care for a low price. When Companies conduct expensive research the companies want to make profit. Most of the drugs that have been introduced are expensive and provide few of the benefits that patients expect. According to the American Cancer Society, usually treatments and medications given to patients have side affects that often cause worst health problems to the patients. The process of accumulating components for prospective medications in the use of cancer treatment is an extremely long process. In most cases, the development takes years to even get a single drug to be manufactured for patient consumption. It must go through several fascists of laboratory testing. “From a “target” to a “drug”, to “trial” then finally, an approved medication in the fight against cancer” (Giulio Draetta M.D., 2012) Researchers use unique processes that extract compounds from natural organism sources such as oceans, plants, fungal bacteria. They then use the......

Words: 940 - Pages: 4

Premium Essay

A Breakthrough Treatment for Lung Cancer Approved- Summary

...Times March,2015 A Breakthrough Treatment for Lung Cancer Approved What you need to know about this promising new drug On March 5, a novel way to treat lung cancer won approval from the Food and Drug Administration (FDA). The latest drug, Opdivo, has showed promise with other cancers, and is the first to use the immune system to tackle hard-to-treat lung tumors. Here’s what you need to know. How does the drug work? Opdivo (nivolumab), made by Bristol-Myers Squibb, works the same way that releasing a parking brake frees a car to move. Normally, the immune system is held back from recognizing tumors as foreign and potentially harmful, since tumors are the body’s own cells that grow abnormally. Without such checks, “the immune system will destroy you,” says Dr. James Allison, chair of immunology at MD Anderson Cancer Center who discovered the first such brake that protected cancer cells from the immune system. But nivolumab releases this check on the immune system’s normally voracious appetite for anything it doesn’t recognize, so the body’s own defenses can preferentially recognize tumor cells as targets. In the study submitted by the company to the FDA, 15% of patientsshowed some shrinkage or complete disappearance of their tumors. What makes this drug different from other cancer treatments? Unlike surgery, chemotherapy, radiation or the anti-cancer drugs that interrupt specific signals that tumor cells use to survive, nivolumab doesn’t target the tumor itself. Rather...

Words: 582 - Pages: 3

Premium Essay

The Public Needs to Know

...Needs to Know | English Composition 115 | Professor Charlotte Walker | | Jamie Mahan | 11/21/2013 | “The economic impact of cancer care has increasingly been the target of scrutiny because of the large price tag attached to many of the agents that have become available during the past few years, especially the biologics.” (Nelson, Roxanne, 2008). If the cost of cancer care keeps rising, the doctors are going to have to include costs when it comes to the decision-making process. The doctors are going to have to think about the actual benefits associated with the expensive treatment. The development of new cancer drugs can be an expensive and lengthy process for cancer patients. Cancer Costs More Than Doubled Since ‘90 Cancer research has cost the US government $100 billion since 1971, and the price of care, accounting for inflation, has more than doubled to $90 billion since 1990. “The price of the drugs, and the care tied to their use, can be lowered by shifting to a system which the costs of drugs, tests, and other care are combined in a single-provider payment,” researchers said. Patients concerns about out-of-pocket payments made patients decide how to treat their cancer. Patients that have health insurance have used most or all of their savings to treat their cancer. “We’ve made progress in cancer research, but people are still dying at too high a rate,” (Gibson, 2010). ......

Words: 841 - Pages: 4

Premium Essay

The Public Needs Know

...to Know Life is the possible price a cancer patient may pay while a new cancer drugs are being produced. Why do cancer drugs cost so much for the patients that need the drug to cure or prolong their life? We have all this technology, but why does all the Corporations that handle the product have to put a high price on what saves a life? Who has the last word on if the drug meets the standard to cure the cancer and why does it take so long to find out if it works or not? “A number of innovative cancer treatments have recently entered clinical practice. Some treatments cost as much as $100,000 per year but it has become apparent that many of these expensive new drugs offer uncertain benefits. Some drugs add only a few weeks of survival at a cost of tens of thousands of dollars. If the cost of cancer care continues to rise, the oncologists are likely to be pressured by payers to consider the economic factor. The high impact of cancer care continues to rise and so does the price tag on many of the agents that have become available during the past few years. Because of the tremendous difference in treatment cost, it is crucial to consider the actual benefits associated with treatments that are more expensive.” (Nelson, 2008) Developing new drugs for treating cancer is a lengthy and expensive process. Physicians are constantly looking for new drugs to treat patients with the disease. Cancer patients need to be aware of how new cancer drugs are tested and developed for use in......

Words: 1241 - Pages: 5

Premium Essay

Avastin Biotechnology Product Invesigation

...Biotechnology Product Investigation Part A Biotechnology drug: Bevacizumab Bevacizumab is a drug that acts primarily as an anti-angiogenesis inhibitor, which means its inhibits blood vessel growth. The drug mainly targets a cell protein formed by cancer called Vascular Endothelial Growth Factor (VEGF) which stimulates blood vessel growth. Cancer tumors release a large amount of VEGF which causes new nearby blood vessels to sprout, hence further feeds the cancer tumor with nutrients. These blood vessels also act as a pathway for the cancer to spread throughout the body. Avastin prevents cancer cell proliferation and inhibits endothelial growth by specifically binding to VEGF, preventing further blood vessel growth and may also prevent communication with the tumor and nearby blood vessels preventing connection with a proper blood supply. This drug is applicable to many types of cancer, a few being kidney cancer, ovarian cancer, breast cancer, and colon cancer. It is often paired with chemotherapy as alone the drug does not destroy cancer but simply inhibits its growth. . The drug does was proven to work successfully but the drug can only shrink the cancer and a second-line treatment was shown to have no effect on the already shrank cancer cells. In addition to that it also treats macular degeneration, which is an age related condition that can result in blurred vision or blindness. The drugs were originally derived from a monoclonal antibody generated from mice.......

Words: 374 - Pages: 2